Financials · ACA

Arcosa Inc. (ACA) financials

For the twelve months ended Jun 30, 2026, Arcosa Inc. reported $2.74B of revenue and $491.40M of net income.

Revenue, TTM
$2.74B
Revenue growth, YoY
+9.7%
Net income, TTM
$491.40M
Net income growth, YoY
+433.0%
Net margin
17.9%
Free cash flow, TTM
$135.20M
EPS, diluted, TTM
$9.98
EPS growth, YoY
+430.9%
Cash
$432.10M
Total debt
$1.43B
P/E
14.90
P/S
2.67
Market cap
$7.32B
Annual revenue$2.88B
FY2016FY2025
Annual net income$208.40M
FY2016FY2025
Annual free cash flow$175.50M
FY2016FY2025

ACA revenue and earnings growth

ACA revenueQ2 2026$658.70M

Quarter YoY
+1.7%
QoQ
+15.2%
FY YoY
+12.2%
5Y CAGR
+8.3%

ACA revenue was $658.70M in fiscal Q2 2026 (ended Jun 30, 2026), up 1.7% from a year earlier and up 15.2% from the prior quarter. For the full fiscal 2025 it was $2.88B, up 12.2% from fiscal 2024. Compound annual growth was +8.3% over 5 years. It rose in 7 of the last 9 fiscal years. Fiscal 2025 is the highest of the 10 fiscal years on file.

ACA net incomeQ2 2026$328.50M

Quarter YoY
+450.3%
QoQ
+769.0%
FY YoY
+122.4%
5Y CAGR
+14.3%

ACA net income was $328.50M in fiscal Q2 2026 (ended Jun 30, 2026), up 450.3% from a year earlier and up 769.0% from the prior quarter. For the full fiscal 2025 it was $208.40M, up 122.4% from fiscal 2024. Compound annual growth was +14.3% over 5 years. It rose in 3 of the last 9 fiscal years.

ACA EPSQ2 2026$6.67

Quarter YoY
+446.7%
QoQ
+766.2%
FY YoY
+122.0%
5Y CAGR
+14.2%

ACA diluted EPS was $6.67 in fiscal Q2 2026 (ended Jun 30, 2026), up 446.7% from a year earlier and up 766.2% from the prior quarter. For the full fiscal 2025 it was $4.24, up 122.0% from fiscal 2024. Compound annual growth was +14.2% over 5 years.

ACA free cash flowQ2 2026-$70.00M

FY YoY
-43.8%
5Y CAGR
-0.3%

ACA free cash flow was -$70.00M in fiscal Q2 2026 (ended Jun 30, 2026), compared with $33.40M a year earlier. For the full fiscal 2025 it was $175.50M, down 43.8% from fiscal 2024. Compound annual growth was -0.3% over 5 years. It rose in 3 of the last 9 fiscal years.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue$2.88B$2.57B$2.31B$2.24B$2.04B$1.94B$1.74B$1.46B$1.46B$1.70B
Cost of revenue$2.24B$2.05B$1.86B$1.83B$1.68B$1.55B$1.40B$1.19B$1.17B$1.36B
Gross profit$647.20M$515.20M$443.80M$411.10M$355.90M$382.00M$332.40M$272.00M$294.70M$348.10M
Selling, general and admin$307.10M$320.00M$261.10M$262.80M$256.00M$223.10M$179.50M$153.90M$163.00M$147.30M
Operating income$341.90M$197.60M$217.30M$349.00M$107.30M$151.80M$152.90M$94.90M$131.70M$200.80M
Interest expense$108.80M$70.90M$28.10M$31.00M$23.40M$10.60M$6.80M$900.0K$0$0
Pre-tax income$241.30M$130.00M$195.90M$316.20M$83.60M$138.20M$146.80M$95.00M$130.10M$197.20M
Income tax$32.90M$36.30M$36.70M$70.40M$14.00M$31.60M$33.50M$19.30M$40.40M$74.20M
Net income$208.40M$93.70M$159.20M$245.80M$69.60M$106.60M$113.30M$75.70M$89.70M$123.00M
EPS, basic$4.25$1.92$3.27$5.08$1.44$2.20$2.34$1.55$1.84$2.52
EPS, diluted$4.24$1.91$3.26$5.05$1.42$2.18$2.32$1.54$1.84$2.52
Diluted shares49.0M48.8M48.7M48.5M48.6M48.5M48.4M48.9M48.8M48.8M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Cash and equivalents$214.60M$187.30M$104.80M$160.40M$72.90M$95.80M$240.40M$99.40M$6.80M$14.00M
Receivables$412.60M$350.20M$357.10M$334.20M$310.80M$260.20M$200.00M$291.40M$165.30M-
Inventory$335.90M$359.90M$401.80M$315.80M$324.50M$276.80M$283.30M$252.50M$246.80M-
Current assets$1.11B$954.00M$912.00M$856.80M$767.90M$664.90M$757.20M$667.40M$428.80M-
Goodwill$1.33B$1.36B$990.70M$958.50M$934.90M$794.00M$621.90M$615.20M$494.30M-
Total assets$4.99B$4.92B$3.58B$3.34B$3.19B$2.65B$2.30B$2.17B$1.60B$1.53B
Current liabilities$503.70M$516.00M$431.20M$367.70M$364.00M$310.30M$284.00M$209.50M$174.10M-
Long-term debt$1.51B$1.68B$561.90M$535.90M$664.70M$248.20M$103.60M$183.70M$400.0K-
Total debt$1.51B$1.68B$561.90M$535.90M$664.70M$248.20M$103.60M$183.70M$400.0K-
Total liabilities$2.34B$2.49B$1.25B$1.16B$1.23B$754.50M$512.10M$487.70M$194.60M-
Shareholders' equity$2.64B$2.43B$2.33B$2.18B$1.95B$1.89B$1.79B$1.68B$1.41B$1.34B

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Operating cash flow$341.10M$502.00M$261.00M$174.30M$166.50M$259.90M$358.80M$118.50M$162.00M$227.80M
Capital expenditures$165.60M$189.70M$203.50M$138.00M$85.10M$82.10M$85.40M$44.80M$82.40M$84.80M
Free cash flow$175.50M$312.30M$57.50M$36.30M$81.40M$177.80M$273.40M$73.70M$79.60M$143.00M
Investing cash flow-$121.40M-$1.51B-$285.80M$90.70M-$570.30M-$528.20M-$109.40M-$364.50M-$126.40M-$79.80M
Financing cash flow-$192.40M$1.09B-$30.80M-$177.50M$380.90M$123.70M-$108.40M$338.60M-$42.80M-$144.20M
Dividends paid$10.00M$9.70M$9.80M$9.80M$9.80M$9.80M$9.90M$2.40M--
Share repurchases$0$0$13.80M$15.00M$9.40M$8.00M$11.00M$3.00M$0$0
Stock-based compensation$26.40M$24.30M$23.90M$19.10M$18.00M$20.00M$14.60M$9.90M$9.00M$10.50M
Depreciation and amortization$223.00M$195.00M$159.50M$154.10M$144.30M$114.50M$85.80M$67.60M$65.70M$65.60M

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue growth, YoY12.2%11.4%2.9%10.1%5.2%11.4%18.9%-0.1%-14.2%-
Net income growth, YoY122.4%-41.1%-35.2%253.2%-34.7%-5.9%49.7%-15.6%-27.1%-
EPS growth, YoY122.0%-41.4%-35.4%255.6%-34.9%-6.0%50.6%-16.3%-27.0%-
Gross margin22.4%20.0%19.2%18.3%17.5%19.7%19.1%18.6%20.2%20.4%
Operating margin11.9%7.7%9.4%15.6%5.3%7.8%8.8%6.5%9.0%11.8%
Net margin7.2%3.6%6.9%11.0%3.4%5.5%6.5%5.2%6.1%7.2%
Free cash flow margin6.1%12.2%2.5%1.6%4.0%9.2%15.7%5.0%5.4%8.4%
Return on equity7.9%3.9%6.8%11.3%3.6%5.6%6.3%4.5%6.4%9.2%
Return on assets4.2%1.9%4.4%7.4%2.2%4.0%4.9%3.5%5.6%8.1%
Current ratio2.201.852.122.332.112.142.673.192.46-
Debt to equity0.570.690.240.250.340.130.060.110.00-

Source: XBRL data Arcosa Inc. files with the SEC, latest filing dated Aug 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

ACA peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
ACA$2.74B+9.7%$491.40M17.9%$7.32B
PH$22.41B+11.9%$3.72B16.6%$115.74B
HWM$9.73B+22.0%$2.05B21.1%$81.84B
RS$17.37B+24.7%$1.11B6.4%$21.24B
RBC$2.02B+17.4%$354.40M17.5%$15.02B
CR$2.76B+21.5%$342.00M12.4%$11.63B
WTS$2.79B+18.7%$447.00M16.0%$11.56B
MLI$5.00B+20.8%$863.59M17.3%$11.54B
GNRC$4.62B+6.1%$301.26M6.5%$10.43B

ACA FAQ

9 questions
  • What is ACA revenue?
    Arcosa Inc. (ACA) reported $2.74B of revenue for the twelve months ended Jun 30, 2026. That is up 9.7% from the year before. Revenue for fiscal 2025 was $2.88B.
  • Is ACA profitable?
    Yes. Arcosa Inc. earned $491.40M in net income for the twelve months ended Jun 30, 2026, a net margin of 17.9%.
  • How much cash and debt does ACA have?
    Arcosa Inc. reported $432.10M in cash and cash equivalents and $1.43B of debt on its most recent balance sheet in SEC filings.
  • How fast is ACA revenue growing?
    Arcosa Inc.'s revenue changed +12.2% in fiscal 2025, to $2.88B. Its compound annual growth rate was +8.3% over 5 years.
  • What is ACA gross margin?
    Arcosa Inc.'s gross profit was $632.30M on $2.74B of revenue for the twelve months ended Jun 30, 2026, a gross margin of 23.0%.
  • What is ACA free cash flow?
    Arcosa Inc. generated $135.20M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $341.30M less capital expenditures.
  • What is ACA earnings per share?
    Diluted earnings per share were $9.98 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did ACA last report financial results?
    The latest statements here come from Arcosa Inc.'s 10-Q filed on Aug 5, 2026, covering the period ended Jun 30, 2026.
  • Where does this ACA financial data come from?
    Quantisnow builds these statements from the structured XBRL data Arcosa Inc. files with the SEC. It is provided for information only and is not investment advice.